Dose. Route. Units. Given. Special situations. Dose. Route. Units. Given. Special situations
|
|
- Ada Blair
- 6 years ago
- Views:
Transcription
1 Chapter 3 Cardiology Georgia Woodfield ASPIRIN FONDAPARINUX 300 once only in acute MI 75 in primary/ secondary prevention of thrombus formation and thromboembolic disease or PR; can also be given via nasogastric tube Once daily May predispose to GI bleeding. Can cause a hypersensitivity reaction with bronchospasm, rhinorrhoea, urticaria and angioedema. 2.5 in acute MI once daily for up to 5 days SC Once daily Increased bleeding risk. Do not use in severe renal failure (egfr <30 ml/min). MORPHINE SULPHATE for chest pain CLOPIDOGREL 300 stat (in acute MI) then 75 daily in primary/ secondary prevention of thrombus formation, can also be given via nasogastric tube Once daily Increases bleeding risk. IV; different formulations of morphine can be given via different routes (see Chapter 7) No maximum; dose is titrated according to response, and presence of any signs of opiate toxicity such as respiratory depression and decreasing consciousness Regular opiate users may have very high requirements, whereas opiate naïve patients may find 2.5 sufficient. Essential Practical Prescribing, First Edition. Georgia Woodfield, Benedict Lyle Phillips, Victoria Taylor, Amy Hawkins and Andrew Stanton by John Wiley & Sons, Ltd. Published 2016 by John Wiley & Sons, Ltd.
2 METOCLOPRAMIDE 10 or IV Up to three times in 24 hours Metoclopramide can cause an oculogyric crisis due to its effect on dopamine receptors (see Chapter 7). This occurs particularly in young women, although is rare. Procyclidine reverses this unwanted symptom. GLYCERYL TRINITRATE (GTN) SPRAY 2 sprays (each spray is 0.3 ) Sublingual Sprays at a time, repeat as required Causes headache due to vasodilation of vessels in the head (as well as the desired coronary vessels). This can limit use. GLYCERYL TRINITRATE (GTN) INFUSION 1 10 per hour IV As an infusion over 24 hours Titrate to blood pressure, as it will invariably drop blood pressure due to vasodilation. Ideally aim for the maximum dose, or dose that will adequately control pain without dropping BP to less than 90 systolic. Again, it can cause headache. FUROSEMIDE 40 as a starting point IV; can be given but will take longer to work As required If patient is already on high doses of furosemide, 40 may not be enough. Consider doubling patient s usual maintenance.
3 GLYCERYL TRINITRATE (GTN) SPRAY 2 sprays (each spray is 0.3 ) Sublingual Sprays at a time, repeat as required Causes headache due to vasodilation of vessels in the head (as well as the desired coronary vessels). This can limit use. GLYCERYL TRINITRATE (GTN) INFUSION 1 10 per hour IV MORPHINE SULPHATE for pulmonary oedema IV; different formulations of morphine can be given via different routes (see Chapter 7) No maximum however this is being given for vasodilation and calming effect, therefore high doses are not required. is titrated according to response, and consciousness levels Monitor carefully for respiratory depression or decreasing consciousness as this is very detrimental to a patient already in respiratory distress. As an infusion over 24 hours Titrate to blood pressure, as it will invariably drop blood pressure due to vasodilation. Ideally aim for the maximum dose, or dose that will adequately control pain without dropping BP to less than 90 mmhg systolic. Again can cause headache. METOCLOPRAMIDE 10 or IV Up to three times in 24 hours Metoclopramide can cause an oculogyric crisis due to its effect on dopamine receptors (see Chapter 7). This occurs particularly in young women, although is rare. Procyclidine reverses this unwanted symptom.
4 ENALAPRIL BISOPROLOL 2.5 aiming for Start at 2.5 BD, aiming for BD 1.25 starting, aiming for 10, aiming for 10 ACEIs will cause a degree of renal impairment. Allow a <50% deterioration in baseline creatinine; however, renal function that is poor may limit dosing. None CARVEDILOL RAMIPRIL 2.5, aiming for 10 Start at 2.5, aiming for 10 ACEIs will cause a degree of renal impairment. Allow a <50% deterioration in baseline creatinine; however, renal function that is poor may limit dosing. LISINOPRIL 2.5 aiming for BD starting dose BD, aiming for BD None METOPROLOL 50 starting, aiming for 200, can also be given IV but not for chronic LVF, aiming for 200 None Start at 2.5, aiming for ACEIs will cause a degree of renal impairment. Allow a <50% deterioration in baseline creatinine; however, renal function that is poor may limit dosing.
5 SPIRONOLACTONE FUROSEMIDE 25 starting dose, aiming for (max dose daily, discuss with senior) or BD Note that this chronic heart failure dose is different to the higher dose used in chronic liver disease and other requiring more significant diuresis. EPLERENONE 25 starting dose, aiming for 50 Titrate dose to tolerance, blood pressure and electrolyte control. Heart failure patients will be on other medications that are beneficial to survival, hence furosemide dose must fit around the optimum doses of these medications as first priority. BENDROFLUMETHIAZIDE 2.5 Eplerenone is used in preference to spironolactone post-mi. Useful in severe heart failure where resistance to loop diuretics has occurred (see Section Diuretics: Rationale and Evidence).
6 VALSARTAN BISOPROLOL 40 aiming for 160 BD 2.5 (up to maximum of 10 ) Start at 40 BD, aiming for 160 BD ARBs (like ACEIs) will cause a degree of renal impairment. Allow a <50% deterioration in baseline creatinine; however, renal function that is poor may limit dosing. DIGOXIN 250 micrograms micrograms Note this dose differs from the higher doses that may be used for rate control of atrial fibrillation. Digoxin levels must be monitored as it has a narrow therapeutic window (see Digoxin Toxicity). Levels are best taken 7 10 days after starting treatment. Do not use in asthma/copd, uncontrolled heart failure, sick sinus syndrome, heart block, hypotension or severe peripheral vascular disease. ORAL METOPROLOL 50 TDS; can give up to 300 daily in divided doses Do not use first line in asthma/ COPD, uncontrolled heart failure, sick sinus syndrome, heart block, hypotension or severe peripheral vascular disease.
7 IV METOPROLOL 1 5, give in 1 aliquots max total dose is 15 IV Give, then wait 5 10 minutes, repeat if no response 5 is a common dose, but it is less risky to give smaller doses and repeat rather than give the full 5 at the start Do not use first line in asthma/ COPD, uncontrolled heart failure, sick sinus syndrome, heart block, hypotension or severe peripheral vascular disease. DIGOXIN 500 microgram loading dose 2 (separated by 6 hours) or IV micrograms Give second dose after 4 6 hours then continue daily oral maintenance dose of micrograms once daily May be used first line for AF in the elderly, immobile or where beta-blockers are contraindicated. Check digoxin levels after hours as maintenance dose may need adjustment. Typically, digoxin levels should be ng/ml. Do not use in heart block, Wolff Parkinson White syndrome, ventricular tachycardias (VT) as it may potentiate the use of the abnormal conduction pathways by slowing the atrioventricular (AV) node (normal) conduction.
8 DILTIAZEM 60 or IV TDS Do not give in heart failure, hypotension, sick sinus syndrome, bradycardia, 2nd or 3rd degree heart block (without pacemaker), AF with WPW, VT, pregnancy and breast feeding. Caution with beta-blockers risk of bradycardia, AV block and arrhythmias. NB: there are numerous longeracting maintenance formulations where brand name must be specified, e.g. Adizem-SR and Tildiem LA. Seek advice from senior/ cardiologist if you are unfamiliar with this drug. VERAPAMIL 40 oral or 5 IV or IV TDS Do not give in heart failure, hypotension, sick sinus syndrome, bradycardia, 2nd or 3rd degree heart block (without pacemaker), AF with WPW, VT, pregnancy and breast feeding. Do not give with beta-blockers risk of bradycardia, AV block and arrhythmias. Seek advice from senior/ cardiologist if you are unfamiliar with this drug.
9 ADENOSINE 6 IV Stat. If ineffective, repeat with 9, then 12 if required Must be given via large-bore cannula in antecubital fossa and flushed immediately with 5 10 ml normal saline otherwise it will not be effective. Do not use in Wolff Parkinson White syndrome or where there is a known aberrant pathway. Adenosine will block the AV node and therefore potentiate conduction through the abnormal pathway in these. Adenosine can precipitate AF due to its effect of atrial tissue. Where there is an aberrant pathway present, this can precipitate VT or VF due to conduction of AF down the aberrant pathway. Contraindications: asthma or bronchospasm from other causes. AMIARONE first dose 300 loading dose IV via a central line (or at very least through large bore cannula in antecubital fossa check with local guidance) Over 1 hour Irritant to blood vessels, hence preferable to give IV amiodarone via a central line. If it is given via a peripheral cannula and then extravasates, it causes painful inflammation to skin. Can cause hypokalaemia and hypotension when given IV. Can cause severe hepatocellular toxicity, even acutely. Can cause arrhythmias due to the fact it can prolong the QT interval, hence use in extreme caution with other drugs that cause prolonged QT. Contraindications: sinus bradycardia, sinoatrial heart block (unless pacemaker fitted), iodine sensitivity. AMIARONE second dose 900 prolonged loading dose, given after the first 300 loading dose has run through IV via a central line Over 23 hours As above. Maximum dose is 1.2 g in 24 hours.
10 maintenance AMIARONE MAGNESIUM SULPHATE 200 maintenance dose oral Three times daily for 1 week then twice daily for 1 week then once daily Different cardiologists may alter this typical regimen of oral dosing, also practices in different trusts vary. Amiodarone has many longterm side effects, many of which are irreversible. It is a toxic and unpleasant drug. See Section Amiodarone: Essential Pharmacology for numerous side effects and cautions. 4 8 mmol (1 2 tablets) of magnesium glycerophosphate mmol (there is generally 4 mmol in one tablet) Up to TDS There is a significant interrelationship between the plasma concentrations of magnesium and potassium, where abnormalities of either can cause arrhythmias. Potassium levels should therefore also be checked at the same time, and potassium replaced if needed. Main things to remember are: Arrhythmogenic Check thyroid and liver function tests every 6 months Can cause hypokalaemia Check colour vision. MAGNESIUM SULPHATE 2 g IV grams over 2 hours This dose is for rapid replacement of Mg rather than everyday prescribing.
11 TASSIUM CHLORIDE mmol of KCl in 1 L of 0.9% saline IV mmol No faster than 10 mmol KCl per hour (max rate) KCl given neat would cause fatal arrhythmias, hence it is always diluted in saline 0.9% or dextrose 5% in a premixed fluid bag and given slowly. Nurses no longer make up the fluid bags on the ward for fear of concentration errors. This situation may be different in intensive care settings, but even in ITU the pharmacy tends to mix the fluid for non-standard potassium prescriptions. There is a significant interrelationship between the plasma concentrations of magnesium and potassium, where abnormalities of either can cause arrhythmias. Magnesium levels should therefore also be checked at the same time, and Mg replaced if needed. ATROPINE 0.5 IV Stat Give up to 3 if ineffective at first May be ineffective in third-degree heart block. If an overdose is given, the antidote is physostigmine or pilocarpine. Side effects are dose related: blurred vision, dry mouth, urinary retention. Can cause confusion in the elderly. RAMPRIL ACEIs will cause a degree of renal impairment. Allow a <50% deterioration in baseline creatinine; however, renal function that is poor may limit dosing. Contraindicated in renal artery stenosis, due to substantial reduction on glomerular filtration rate, leading to severe and progressive renal failure.
12 ENALAPRIL LOSARTAN ACEIs will cause a degree of renal impairment. Allow a <50% deterioration in baseline creatinine; however, renal function that is poor may limit dosing. Contraindicated in renal artery stenosis, due to substantial reduction on glomerular filtration rate, leading to severe and progressive renal failure. Note this is a higher dose than when used for chronic heart failure (12.5 ). can be up-titrated to 100. Use with caution in renal artery stenosis. Use with caution in chronic renal impairment; contraindicated where egfr <60 ml/min/1.73 m 2. LISINOPRIL ACEIs will cause a degree of renal impairment. Allow a <50% deterioration in baseline creatinine; however, renal function that is poor may limit dosing. Contraindicated in renal artery stenosis, due to substantial reduction on glomerular filtration rate, leading to severe and progressive renal failure. CANDESARTAN 8 Oral Max dose is 32. for heart failure is usually lower (4 starting dose). See losartan for cautions.
13 ATENOLOL FELIPINE This is a lower dose than for arrhythmias and angina (up to 100 daily). Contraindicated in asthma and COPD with bronchoconstriction. Common side effect is peripheral oedema. INDAPAMIDE BISOPROLOL Commonly causes hyponatraemia. Used as an adjunct in heart failure, usually at , Contraindicated in asthma and COPD with bronchoconstriction. BENDROFLUMETHIAZIDE AMLIPINE 5 10 Common side effect is peripheral oedema.
14 METOLAZONE 5 on alternate days Metolazone is a potent diuretic and can cause profound prerenal renal dysfunction. For this reason low doses are given for hypertension treatment, often on alternate days. For resistant oedema higher doses of 80 (maximum) can be given, but this is a very high dose.
Adenosine. poison/drug induced. flushing, chest pain, transient asystole. Precautions: tachycardia. fibrillation, atrial flutter. Indications: or VT
Adenosine Indications: 1. Narrow complex PSVT 2. Does not convert atrial fibrillation, atrial flutter or VT 1. Side effects include flushing, chest pain, transient asystole 2. May deteriorate widecomplex
More informationHeart Failure Clinician Guide JANUARY 2018
Kaiser Permanente National CLINICAL PRACTICE GUIDELINES Heart Failure Clinician Guide JANUARY 2018 Introduction This evidence-based guideline summary is based on the 2018 National Heart Failure Guideline.
More informationHeart Failure Clinician Guide JANUARY 2016
Kaiser Permanente National CLINICAL PRACTICE GUIDELINES Heart Failure Clinician Guide JANUARY 2016 Introduction This evidence-based guideline summary is based on the 2016 National Heart Failure Guideline.
More informationCARDIAC REHABILITATION PROGRAMME:- MEDICATION
CARDIAC REHABILITATION PROGRAMME:- MEDICATION AIM OF THIS SESSION Understand the reasons for taking your medications, Discuss the common side effects associated with these medications - knowing when to
More informationChapter 2 ~ Cardiovascular system
Chapter 2 ~ Cardiovascular System: General Section 1 of 6 Chapter 2 ~ Cardiovascular system 2.1 Positive inotropic drugs 2.1.1 Cardiac glycosides DIGOXIN 2.2 Diuretics Elixir 50micrograms in 1ml Injection
More informationPHARMACOLOGICAL PROBLEMS
PHARMACOLOGICAL PROBLEMS 1. A 69 year old woman suffering from CHF has been treated with.25 mg Digoxin tablet daily for last 3 months. But the heart failure is not controlled adequately. What will be the
More informationHeart Failure (HF) Treatment
Heart Failure (HF) Treatment Heart Failure (HF) Complex, progressive disorder. The heart is unable to pump sufficient blood to meet the needs of the body. Its cardinal symptoms are dyspnea, fatigue, and
More informationChapter (9) Calcium Antagonists
Chapter (9) Calcium Antagonists (CALCIUM CHANNEL BLOCKERS) Classification Mechanism of Anti-ischemic Actions Indications Drug Interaction with Verapamil Contraindications Adverse Effects Treatment of Drug
More informationCardiology. Self Learning Package. Module 5: Pharmacology: Treatment of Acute Coronary. Prevention
Cardiology Self Learning Package Module 5: Pharmacology: Treatment of Acute Coronary Syndromes, Module 5: Pharmacology: Hyperlipidaemia, Treatment of Acute Coronary Hypertension, Symdrome, Hyperlipidaemia,
More informationAntihypertensive drugs: I. Thiazide and other diuretics:
Clinical assessment of hypertensive patient: You have to take history regarding the presence of other risk factors for CAb like diabetes mellitus, smoking, etc. Take history whether the patient takes medications
More informationPlatelet aggregation inhibitor. Cardiac chest pain or suspected Myocardial Infarction.
s Aspirin Platelet aggregation inhibitor. Anti-inflammatory agent and an inhibitor of platelet function. Useful agent in the treatment of various thromboembolic diseases such as acute myocardial infarction.
More informationChapter 2 - Cardiovascular System. Primary Care Prescribing Formulary - Preferred Drug Choices
Chapter 2 - Cardiovascular System Primary Care Prescribing Formulary - Preferred Drug Choices Drug group Drug choice Comments/notes Cardiac glycosides Thiazide diuretics Loop diuretics Aldosterone antagonist
More informationChapter 9. Learning Objectives. Learning Objectives 9/11/2012. Cardiac Arrhythmias. Define electrical therapy
Chapter 9 Cardiac Arrhythmias Learning Objectives Define electrical therapy Explain why electrical therapy is preferred initial therapy over drug administration for cardiac arrest and some arrhythmias
More informationChapter / Section / Drug
2 Cardiovascular System 2.1 Positive inotropic drugs Digoxin Digoxin specific antibody ( DigiFab ) 2.2 Diuretics 2.2.1 Thiazides and related diuretics Indapamide (1 st Line) Bendroflumethiazide Metolazone
More information1/4/18. Heart Failure Guideline Review and Update. Disclosure. Pharmacist Objectives. Pharmacy Technician Objectives. What is Heart Failure?
Disclosure Heart Failure Guideline Review and Update I have had no financial relationship over the past 12 months with any commercial sponsor with a vested interest in this presentation. Natalie Beiter,
More informationADULT DRUG REFERENCE Drug Indication Adult Dosage Precautions / Comments
ADENOSINE Paroxysmal SVT 1 st Dose 6 mg rapid IV 2 nd & 3 rd Doses 12 mg rapid IV push Follow each dose with rapid bolus of 20 ml NS May cause transient heart block or asystole. Side effects include chest
More informationCardiovascular system
Contents: Cardiovascular system 1. Hypertension 2 2. Hypertensive crises 4 3. Heart failure acute 5 4. Heart failure (chronic management) 6 5. Acute chest pain, angina and acute coronary syndromes (including
More informationCardiovascular Pharmacotherapy
Cardiovascular Pharmacotherapy Overview Mechanism of cardiovascular drugs Indications and clinical use in cardiology Renin-Angiotensin Inhibitors: Angiotensin-Converting Enzyme Inhibitors, Angiotensin
More informationReview guidance for patients on long-term amiodarone treatment
Review guidance for patients on long-term amiodarone treatment This review guidance document has been produced in response to: 1. Current supply shortages of branded and generic versions of 100mg and 200mg
More informationANTI-ARRHYTHMICS AND WARFARIN. Dr Nithish Jayakumar
ANTI-ARRHYTHMICS AND WARFARIN Dr Nithish Jayakumar Contents 1. Anti-arrhythmics Pacemaker and myocardial potentials Drug classes mechanisms; s/e; contra-indications Management of common arrhythmias 2.
More informationInverclyde CHP Protected Learning Event- Heart Failure
Inverclyde CHP Protected Learning Event- Heart Failure 14:00 14:05 14:05 14:20 14:20 14:30 14:30 15:10 15:10 15:30 15:30 15:50 15:50 16:05 16:05 16:35 Welcome & Introduction Paul Forsyth (HF Pharmacist)
More informationIntroductory Clinical Pharmacology Chapter 41 Antihypertensive Drugs
Introductory Clinical Pharmacology Chapter 41 Antihypertensive Drugs Blood Pressure Normal = sys
More informationYounger adults with a family history of premature artherosclerotic disease should have their cardiovascular risk factors measured.
Appendix 2A - Guidance on Management of Hypertension Measurement of blood pressure All adults from 40 years should have blood pressure measured as part of opportunistic cardiovascular risk assessment.
More informationSTANDARD treatment algorithm mmHg
STANDARD treatment algorithm 130-140mmHg (i) At BASELINE, If AVERAGE SBP 1 > 140mmHg If on no antihypertensive drugs: Start 1 drug: If >55 years old / Afro-Caribbean: Calcium channel blocker (CCB) 2 If
More informationALS MODULE 7 Pharmacology
ALS MODULE 7 Pharmacology Relates to HLT404C Apply Advanced Resuscitation Techniques Introduction There are no studies that addressed the order of drug administration. There is inadequate evidence to define
More informationChapter 5 Gastroenterology. Dose. Route. Units. Given. Dose. Route. Units. Given
Chapter 5 Gastroenterology Georgia Woodfield TERLIPRESSIN CIPROFLOXACIN 2 initial dose 500 Every 4 hours until bleeding controlled can be reduced to 1 after initial dose if side effects develop or if patient
More informationObjectives: This presentation will help you to:
emergency Drugs Objectives: This presentation will help you to: Five rights for medication administration Recognize different cardiac arrhythmias and determine the common drugs used for each one List the
More informationCardiovascular Health Practice Guideline Outpatient Management of Coronary Artery Disease 2003
Authorized By: Medical Management Guideline Committee Approval Date: 12/13/01 Revision Date: 12/11/03 Beta-Blockers Nitrates Calcium Channel Blockers MEDICATIONS Indicated in post-mi, unstable angina,
More informationManagement of Hypertension
Clinical Practice Guidelines Management of Hypertension Definition and classification of blood pressure levels (mmhg) Category Systolic Diastolic Normal
More informationAF in the ER: Common Scenarios CASE 1. Fast facts. Diagnosis. Management
AF in the ER: Common Scenarios Atrial fibrillation is a common problem with a wide spectrum of presentations. Below are five common emergency room scenarios and the management strategies for each. Evan
More informationDr Narender Goel MD (Internal Medicine and Nephrology) Financial Disclosure: None, Conflict of Interest: None
Dr Narender Goel MD (Internal Medicine and Nephrology) drnarendergoel@gmail.com Financial Disclosure: None, Conflict of Interest: None 12 th December 2013, New York Visit us at: http://kidneyscience.info/
More informationContents: 1. Hypertension
Contents: Cardiovascular system Medicines Formulary 1. Hypertension 2 2. Hypertensive crises 4 3. Heart failure acute 5 4. Heart failure (chronic management) 6 5. Acute chest pain, angina and acute coronary
More informationGuideline-Directed Medical Therapy
Guideline-Directed Medical Therapy Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients with Functional Mitral Regurgitation OPTIMAL THERAPY (As defined in
More informationEvaluation and Management of Acute Decompensated Heart Failure (HF) with Reduced Ejection Fraction Systolic Heart Failure (HFrEF)(EF<40%
Evaluation and Management of Acute Decompensated Heart Failure (HF) with Reduced Ejection Fraction Systolic Heart Failure (HFrEF)(EF
More informationTarget dose achievement of evidencebased medications in patients with heart failure with reduced ejection fraction attending a heart failure clinic
Target dose achievement of evidencebased medications in patients with heart failure with reduced ejection fraction attending a heart failure clinic June Chen 1, Charlotte Galenza 1, Justin Ezekowitz 2,3,
More informationAcute Arrhythmias in the Hospitalized Patient
Acute Arrhythmias in the Hospitalized Patient Gregory M Marcus, MD, MAS Associate Professor of Medicine Division of Cardiology University of California, San Francisc Disclosures Medtronic: Research Support
More informationThe dose for paediatric patients may never exceed the adult dose.
The medication formulary is published by the Pre-Hospital Emergency Care Council (PHECC) to support Emergency First Responders to be competent in the use of medications permitted under Clinical Practice
More informationAdult Drug Reference. Dopamine Drip Chart. Pediatric Drug Reference. Pediatric Drug Dosage Charts DRUG REFERENCES
Adult Drug Reference Dopamine Drip Chart Pediatric Drug Reference Pediatric Drug Dosage Charts DRUG REFERENCES ADULT DRUG REFERENCE Drug Indication Adult Dosage Precautions / Comments ADENOSINE Paroxysmal
More informationBlood pressure parameters for iv amiodarone
Blood pressure parameters for iv amiodarone Search 17-7-2012 ICU & Fluids - Electrolytes - Nutrition: Edited by Andy S. Binder, MD, Pulmonologist, Critical Care. Contents: Electrolytes : Fluids: Dehydration.
More informationAPPENDIX 1 - MEDICATION FORMULARY
The medication formulary is published by the Pre-Hospital Emergency Care Council (PHECC) to enable pre-hospital emergency care Responders to be competent in the use of medications permitted under Clinical
More information5mg/5mL Liquid 25mg Tablets 50mg Tablets 100mg Tablets 50mg/5mL Suspension Special standardise strength 25mg Tablets
Chapter 2- Cardiovascular Category Drug name Strength / dose / form BCU 2.1 Positive Inotropic drugs 2.1.1 Cardiac Digoxin 62.5 microgram Tablets Glycosides 125 microgram Tablets 250 microgram Tablets
More informationShared Care Guideline Metolazone for fluid management in CKD (Adults)
Shared Care Guideline Metolazone for fluid management in CKD (Adults) It is vital for safe and appropriate patient care that there is a clear understanding of where clinical and prescribing responsibility
More informationAntihypertensive drugs SUMMARY Made by: Lama Shatat
Antihypertensive drugs SUMMARY Made by: Lama Shatat Diuretic Thiazide diuretics The loop diuretics Potassium-sparing Diuretics *Hydrochlorothiazide *Chlorthalidone *Furosemide *Torsemide *Bumetanide Aldosterone
More informationWhat is Hypertension?
What is Hypertension? What is hypertension? Hypertension is also known as high blood pressure. Our blood needs to be under pressure to make it move around the body, but when it is too high this causes
More information5.2 Key priorities for implementation
5.2 Key priorities for implementation From the full set of recommendations, the GDG selected ten key priorities for implementation. The criteria used for selecting these recommendations are listed in detail
More informationResuscitation Fluids
Resuscitation Fluids Acceptable Fluids (also known as): Sodium Chloride Hartmann s Solution (Ringer-Lactate Solution, Compound Sodium Lactate) 4.5% Albumin Solution (PPS) Gelofusine 20ml/kg Bolus Can be
More informationAntihypertensive Agents Part-2. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia
Antihypertensive Agents Part-2 Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia Agents that block production or action of angiotensin Angiotensin-converting
More informationDisclosures. This speaker has indicated there are no relevant financial relationships to be disclosed.
Disclosures This speaker has indicated there are no relevant financial relationships to be disclosed. And the Beat Goes On: New Medications for Heart Failure Alison M. Walton, PharmD, BCPS The Case of
More informationNeprilysin Inhibitor (Entresto ) Prior Authorization and Quantity Limit Program Summary
Neprilysin Inhibitor (Entresto ) Prior Authorization and Quantity Limit Program Summary FDA APPROVED INDICATIONS DOSAGE 1 Indication Entresto Reduce the risk of cardiovascular (sacubitril/valsartan) death
More informationAtrial Fibrillation Version 2 11/4/15 This order set must be used with an admission order set if patient not already admitted.
Patient Name: Diagnosis: Allergies with reaction type: Atrial Fibrillation Version 2 11/4/15 This order set must be used with an admission order set if patient not already admitted. Telemetry Medical Telemetry:
More informationHypertension (JNC-8)
Hypertension (JNC-8) Southern California University of Health Sciences Physician Assistant Program Management and Treatment of Hypertension April 17, 2018, presented by Ezra Levy, Pharm.D.! The 8 th Joint
More informationInstruct patient and caregivers: Need for constant monitoring Potential complications of drug therapy
Assessment Prior to administration: Assess patient for chest pain, dysrhythmias, and vital signs (initially and throughout therapy) Obtain complete medical history, including allergies, especially heart
More informationTreatment of Arrhythmias in the Emergency Setting
Treatment of Arrhythmias in the Emergency Setting Zian H. Tseng, M.D. Assistant Professor of Medicine Cardiac Electrophysiology Section Cardiology Division University of California, San Francisco There
More informationSection 3, Lecture 2
59-291 Section 3, Lecture 2 Diuretics: -increase in Na + excretion (naturesis) Thiazide and Related diuretics -decreased PVR due to decreases muscle contraction -an economical and effective treatment -protect
More informationMedications. Your prescriptions can be filled by your home pharmacy or by the Michigan Medicine Taubman Center outpatient pharmacy.
Medications Your prescriptions can be filled by your home pharmacy or by the Michigan Medicine Taubman Center outpatient pharmacy. What do I need to know about medications after my heart attack? When you
More informationDysrhythmias 11/7/2017. Disclosures. 3 reasons to evaluate and treat dysrhythmias. None. Eliminate symptoms and improve hemodynamics
Dysrhythmias CYDNEY STEWART MD, FACC NOVEMBER 3, 2017 Disclosures None 3 reasons to evaluate and treat dysrhythmias Eliminate symptoms and improve hemodynamics Prevent imminent death/hemodynamic compromise
More informationChapter 26. Media Directory. Dysrhythmias. Diagnosis/Treatment of Dysrhythmias. Frequency in Population Difficult to Predict
Chapter 26 Drugs for Dysrythmias Slide 33 Slide 35 Media Directory Propranolol Animation Amiodarone Animation Upper Saddle River, New Jersey 07458 All rights reserved. Dysrhythmias Abnormalities of electrical
More informationHypertension diagnosis (see detail document) Diabetic. Target less than 130/80mmHg
Hypertension diagnosis (see detail document) Non-diabetic Diabetic Very elderly (older than 80 years) Target less than 140/90mmHg Target less than 130/80mmHg Consider SBP target less than 150mmHg Non-diabetic
More informationHeart Failure (HF) - Primary Care Flow Charts. Pre diagnosis Symptoms or signs suggestive of HF
Heart Failure (HF) - Primary Care Flow Charts Pre diagnosis Symptoms or signs suggestive of HF 12 lead ECG Normal examination and 12 lead ECG HF highly unlikely Abnormal 12 lead ECG HF Possible Arrange
More informationHeart Failure (HF) - Primary Care Flow Charts. Symptoms or signs suggestive of HF. Pre diagnosis. Refer to the Heart Failure Clinic at VHK for
Heart Failure (HF) - Primary Care Flow Charts Pre diagnosis Symptoms or signs suggestive of HF 12 lead ECG Normal examination and 12 lead ECG HF highly unlikely Abnormal 12 lead ECG HF Possible Arrange
More informationNetwork Hypertension Algorithm
Network Hypertension Algorithm Content Review and Approval: This document is subject to review, revision, and (re)approval by the Clinical Integration and Oversight Committee (CIOC) annually and following
More informationARNI (Angiotensin Receptor blocker / Neprilysin Inhibitors [Sacubutril/Valsartan]) Heart Failure Medication Initiation and Titration
ARNI (Angiotensin Receptor blocker / Neprilysin Inhibitors [Sacubutril/Valsartan]) Heart Failure Medication and Symptomatic HF despite ACEI/ARB and B-blocker therapy Bilateral renal artery stenosis Moderate/Severe
More informationHeart Failure. Dr. Alia Shatanawi
Heart Failure Dr. Alia Shatanawi Left systolic dysfunction secondary to coronary artery disease is the most common cause, account to 70% of all cases. Heart Failure Heart is unable to pump sufficient blood
More informationAtrial Fibrillation Cases. Dr Paul Broadhurst Consultant Cardiologist
Atrial Fibrillation Cases Dr Paul Broadhurst Consultant Cardiologist November 2011 Mr TH age 72 Routine medical for hypertension check Denies any symptoms despite close questioning PMH: hypertension, MI,
More informationRhythm Control: Is There a Role for the PCP? Blake Norris, MD, FACC BHHI Primary Care Symposium February 28, 2014
Rhythm Control: Is There a Role for the PCP? Blake Norris, MD, FACC BHHI Primary Care Symposium February 28, 2014 Financial disclosures Consultant Medtronic 3 reasons to evaluate and treat arrhythmias
More informationPACKAGE INSERT TEMPLATE FOR SALBUTAMOL TABLET & SALBUTAMOL SYRUP
PACKAGE INSERT TEMPLATE FOR SALBUTAMOL TABLET & SALBUTAMOL SYRUP Brand or Product Name [Product name] Tablet 2mg [Product name] Tablet 4mg [Product name] Syrup 2mg/5ml Name and Strength of Active Substance(s)
More informationByvalson. (nebivolol, valsartan) New Product Slideshow
Byvalson (nebivolol, valsartan) New Product Slideshow Introduction Brand name: Byvalson Generic name: Nebivolol, valsartan Pharmacological class: Beta-blocker + angiotensin II receptor blocker (ARB) Strength
More informationHEART FAILURE PHARMACOLOGY. University of Hawai i Hilo Pre- Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D
HEART FAILURE PHARMACOLOGY University of Hawai i Hilo Pre- Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D 1 LEARNING OBJECTIVES Understand the effects of heart failure in the body
More informationNHS GRAMPIAN MEDICAL TREATMENT GUIDELINES FOR CHRONIC HEART FAILURE (CHF) DUE TO LEFT VENTRICULAR SYSTOLIC DYSFUNCTION (LVSD)
NHS GRAMPIAN MEDICAL TREATMENT GUIDELINES FOR CHRONIC HEART FAILURE (CHF) DUE TO LEFT VENTRICULAR SYSTOLIC DYSFUNCTION (LVSD) MANAGED CLINICAL NETWORK FOR CHRONIC HEART FAILURE November 2006 Review date:
More information7/7/ CHD/MI LVH and LV dysfunction Dysrrhythmias Stroke PVD Renal insufficiency and failure Retinopathy. Normal <120 Prehypertension
Prevalence of Hypertension Hypertension: Diagnosis and Management T. Villela, M.D. Program Director University of California, San Francisco-San Francisco General Hospital Family and Community Medicine
More informationVolume 6; Number 1 January 2012 NICE CLINICAL GUIDELINE 127: HYPERTENSION CLINICAL MANAGEMENT OF PRIMARY HYPERTENSION IN ADULTS (AUGUST 2011)
Volume 6; Number 1 January 2012 NICE CLINICAL GUIDELINE 127: HYPERTENSION CLINICAL MANAGEMENT OF PRIMARY HYPERTENSION IN ADULTS (AUGUST 2011) What s new in hypertension? NICE has issued an updated Clinical
More informationCORDARONE Sanofi-Aventis
CORDARONE Sanofi-Aventis Composition Amiodarone 200 mg; tablets. Also AMPOULES 150 mg/3 ml. Indications Tablets Prevention of recurrence of the following: life-threatening ventricular tachycardias in which
More informationMedicines for high blood pressure
Patient Information: Medicines Medicines for high blood pressure Health & care information you can trust The Information Standard Certified Member Working together for better patient information What is
More informationDon t Forget the Basics
Scary Arrhythmias in the Hospital Gregory M Marcus, MD, MAS Assistant Professor of Medicine Division of Cardiology University of California, San Francisc Don t Forget the Basics 79 yo man with a history
More informationHEART FAILURE SUMMARY. and is associated with significant morbidity and mortality. the cornerstone of heart failure treatment.
HEART FAILURE SUMMARY + Heart Failure is a condition affecting a large number of Irish people and is associated with significant morbidity and mortality. + ACE inhibitors, in combination with diuretics,
More informationGuidelines for the Prescribing of Sacubitril / Valsartan
Hull & East Riding Prescribing Committee Guidelines for the Prescribing of Sacubitril / Valsartan 1. BACKGROUND Sacubitril valsartan is an angiotensin receptor neprilysin inhibitor, including both a neprilysin
More informationMedical Treatment for acute Decompensated Heart Failure. Vlasis Ninios Cardiologist St. Luke s s Hospital Thessaloniki 2011
Medical Treatment for acute Decompensated Heart Failure Vlasis Ninios Cardiologist St. Luke s s Hospital Thessaloniki 2011 2010 HFSA guidelines for ADHF 2009 focused update of the 2005 American College
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. Active substance: enoximone
PACKAGE LEAFLET 1 PACKAGE LEAFLET: INFORMATION FOR THE USER Perfan Injection 100 mg/20 ml Concentrate for Solution for Injection Active substance: enoximone Read all of this leaflet carefully before you
More informationDrug Max dose approved for IVP Dilution Rate Monitoring Parameters. Dilution not necessary (Available in prefilled syringe)
Drug Max dose approved for IVP Dilution Rate Monitoring Parameters Acetazolamide 500 mg Reconstitute with at least 5ml sterile water (max concentration should not exceed 100mg/ml) 100-500 mg/min Hypotension
More informationManagement of ATRIAL FIBRILLATION. in general practice. 22 BPJ Issue 39
Management of ATRIAL FIBRILLATION in general practice 22 BPJ Issue 39 What is atrial fibrillation? Atrial fibrillation (AF) is the most common cardiac arrhythmia encountered in primary care. It is often
More informationAntihypertensive Agents
Antihypertensive Agents Southern California University of Health Sciences Physician Assistant Program Management and Treatment of Hypertension April 7, 08, presented by Ezra Levy, Pharm.D! Usual Dose,
More informationLXIV: DRUGS: 4. RAS BLOCKADE
LXIV: DRUGS: 4. RAS BLOCKADE ACE Inhibitors Components of RAS Actions of Angiotensin i II Indications for ACEIs Contraindications RAS blockade in hypertension RAS blockade in CAD RAS blockade in HF Limitations
More informationAtrial fibrillation in the ICU
Atrial fibrillation in the ICU Atrial fibrillation Preexisting or incident (new onset) among nearly one in three critically ill patients Formation of arrhythogenic substrate usually fibrosis (CHF, hypertension,
More informationPharmaceutical form(s)/strength: Solution: 5 mg/ml Suspensions: 2.5 and 5 mg/ml P-RMS:
0BCore Safety Profile Active substance: Betaxolol eyedrops Pharmaceutical form(s)/strength: Solution: 5 mg/ml Suspensions: 2.5 and 5 mg/ml P-RMS: HU/H/PSUR/0010/002 Date of FAR: 20.03.2013 4.2 Posology
More informationDRUG GUIDELINE. HYDRALAZINE (Intravenous severe hypertension in pregnancy)
DRUG GUIDELINE HYDRALAZINE (Intravenous severe hypertension SCOPE (Area): FOR USE IN: Labour Ward, HDU, Theatre and ED EXCLUSIONS: Paediatrics (seek Paediatrician advice) and other general wards. SCOPE
More informationClinical Practice Guidelines Edition (Updated February 2018)
The Formulary is published by the Pre-Hospital Emergency Care Council (PHECC) to support Emergency First Responders to be competent in the use of medications permitted under Clinical Practice Guidelines
More informationMedications and your Heart. RBCH Foundation Trust
Medications and your Heart RBCH Foundation Trust Today I will try and cover Confusing cocktail of drugs? What are they for? How do I take them? What if I forget to take them? What are common side effects?
More informationCardiac Catheter Labs Intravenous Drug Therapy Guide
Title of Guideline (must include the word Guideline (not protocol, policy, procedure etc) Contact Name and Job Title (author) Cardiac Catheter Lab IV Medicines Guideline Helen Buxton ( Senior Cath Lab
More informationChapter 23. Media Directory. Cardiovascular Disease (CVD) Hypertension: Classified into Three Categories
Chapter 23 Drugs for Hypertension Slide 37 Slide 41 Media Directory Nifedipine Animation Doxazosin Animation Upper Saddle River, New Jersey 07458 All rights reserved. Cardiovascular Disease (CVD) Includes
More informationThe most common. hospitalized patients. hypotension due to. filling time Rate control in ICU patients may be difficult as many drugs cause hypotension
Arrhythmias in the critically ill ICU patients: Approach for rapid recognition & management Objectives Be able to identify and manage: Atrial fibrillation with a rapid ventricular response Atrial flutter
More informationPEDIATRIC SVT MANAGEMENT
PEDIATRIC SVT MANAGEMENT 1 INTRODUCTION Supraventricular tachycardia (SVT) can be defined as an abnormally rapid heart rhythm originating above the ventricles, often (but not always) with a narrow QRS
More informationNew Winners in the World of Heart Failure. Laura Steffens PharmD Candidate 2016 CICU Presentation August 12, 2015
New Winners in the World of Heart Failure Laura Steffens PharmD Candidate 2016 CICU Presentation August 12, 2015 Jessup 2014 Shaking Things Up 2003: FDA approved eplerenone for the treatment of heart failure
More informationDISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.
DISCLAIMER: Video will be taken at this clinic and potentially used in Project ECHO promotional materials. By attending this clinic, you consent to have your photo taken and allow Project ECHO to use this
More informationHeart Failure: Guideline-Directed Management and Therapy
Heart Failure: Guideline-Directed Management and Therapy Guideline-Directed Management and Therapy (GDMT) was developed by the American College of Cardiology and American Heart Association to define the
More informationMedicine Dr. Omed Lecture 2 Stable and Unstable Angina
Medicine Dr. Omed Lecture 2 Stable and Unstable Angina Risk stratification in stable angina. High Risk; *post infarct angina, *poor effort tolerance, *ischemia at low workload, *left main or three vessel
More informationCardiovascular Clinical Practice Guideline Pilot Implementation
Cardiovascular Clinical Practice Guideline Pilot Implementation Pharmacologic Management of Chronic Heart Failure Sept 15, 2004 Angela Allerman, PharmD, BCPS DoD Pharmacoeconomic Center Promoting high
More informationAntihypertensives. Diagnostic category
Measurement of blood pressure At first assessment, take both arms then choose the one with the higher reading. Beware of orthostatic hypotension. Measure BP in sitting position, and repeat after patient
More informationPackage leaflet: Information for the patient. VEPROL Film coated tablets 40 mg or 80 mg (Verapamil hydrochloride)
Package leaflet: Information for the patient VEPROL Film coated tablets 40 mg or 80 mg (Verapamil hydrochloride) Read this leaflet carefully before you start taking this medicine. - Keep this leaflet.
More informationSTOPP START Toolkit Supporting Medication Review in the Older Person
STOPP START Toolkit Supporting Medication Review in the Older Person STOPP: Screening Tool of Older People s potentially inappropriate Prescriptions START: Screening Tool to Alert doctors to Right (appropriate,
More informationDERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT OF CHRONIC HEART FAILURE with left ventricular systolic dysfunction
DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT OF CHRONIC HEART FAILURE with left ventricular systolic dysfunction o o o o o All heart failure patients with LVSD should be considered for
More information